Home
Conditions
Stage IV Squamous Cell Carcinoma of the Oropharynx

Clinical trial condition

Stage IV Squamous Cell Carcinoma of the Oropharynx

Explore clinical trials studying Stage IV Squamous Cell Carcinoma of the Oropharynx. Study availability and eligibility vary by location and protocol.

21 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage IV Squamous Cell Carcinoma of the Oropharynx trial results

Completed

Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT00084682

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Montefiore Medical Center The Bronx, New York, United States

View Trial Details

Completed

Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck

NCT01044433

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +30 more
Locations: Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma

NCT01064921

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +13 more
Locations: The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00055913

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +18 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

NCT01316757

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +35 more
Locations: Univesity of Rochester Medical Center Rochester, New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Completed

SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00095628

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
Locations: Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

NCT00397384

Conditions: Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, +135 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

NCT00387335

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +19 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

NCT00101348

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +122 more
Locations: Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States

View Trial Details

Completed

Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

NCT00492089

Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Meningioma, +126 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Stage IV Squamous Cell Carcinoma of the Oropharynx

Stage IV Squamous Cell Carcinoma of the Oropharynx trial results

Related conditions